SCM
BMY icon

Sitrin Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Sitrin Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-107,281
Closed -$5.58M – 38
2018
Q4 		$5.58M Buy
+107,281
New +$5.76M 3.4% 15

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sitrin Capital Management's BMY Position: Q1 2019 in Review

Sitrin Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 107,281 shares — an estimated $5.58M sold.

Sitrin Capital Management first reported a position in BMY in Q4 2018 and held it in 1 quarter. The position peaked at $5.58M in Q4 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Sitrin Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Sitrin Capital Management sold 107,281 Bristol-Myers Squibb shares in Q1 2019, an estimated $5.58M.
  • Sitrin Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 1 quarter.
  • Sitrin Capital Management's Bristol-Myers Squibb position peaked at $5.58M in Q4 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Sitrin Capital Management's 13F filing for Q1 2019, filed 11 Apr 2019.